TMO Thermo Fisher Scientific Inc.

Price (delayed)

$471.83

Market cap

$186.65B

P/E Ratio

50.68

Dividend/share

$0.85

EPS

$9.31

Enterprise value

$202.15B

Sector: Healthcare
Industry: Diagnostics & Research
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Highlights

Thermo Fisher Scientific's quick ratio has soared by 101% YoY and by 26% from the previous quarter
Thermo Fisher Scientific's gross profit has increased by 8% YoY and by 4.9% from the previous quarter
The stock's price to earnings (P/E) is 57% more than its 5-year quarterly average of 32.2 and 50% more than its last 4 quarters average of 33.7
The debt has increased by 12% YoY and by 7% QoQ

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
395.59M
Market cap
$186.65B
Enterprise value
$202.15B
Valuations
Price to earnings (P/E)
50.68
Price to book (P/B)
6.24
Price to sales (P/S)
7.1
EV/EBIT
41.42
EV/EBITDA
28.16
EV/Sales
7.7
Earnings
Revenue
$26.25B
EBIT
$4.88B
EBITDA
$7.18B
Free cash flow
$4.28B
Per share
EPS
$9.31
Free cash flow per share
$10.82
Book value per share
$75.64
Revenue per share
$66.45
TBVPS
$57.53
Balance sheet
Total assets
$61.59B
Total liabilities
$31.72B
Debt
$21.31B
Equity
$29.88B
Working capital
$9.76B
Liquidity
Debt to equity
0.71
Current ratio
2.62
Quick ratio
1.71
Net debt/EBITDA
2.16
Margins
EBITDA margin
27.4%
Gross margin
45.4%
Net margin
14.1%
Operating margin
17%
Efficiency
Return on assets
6.3%
Return on equity
12.6%
Return on invested capital
16.6%
Return on capital employed
8.8%
Return on sales
18.6%
Dividend
Dividend yield
0.18%
DPS
$0.85
Payout ratio
9.1%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$26.25B
Gross profit
$11.92B
Operating income
$4.48B
Net income
$3.71B
Gross margin
45.4%
Net margin
14.1%
Thermo Fisher Scientific's gross profit has increased by 8% YoY and by 4.9% from the previous quarter
Thermo Fisher Scientific's operating margin has decreased by 6% YoY and by 5% from the previous quarter
Thermo Fisher Scientific's revenue has increased by 6% YoY and by 2.3% from the previous quarter
Thermo Fisher Scientific's net income has increased by 4.7% YoY

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
50.68
P/B
6.24
P/S
7.1
EV/EBIT
41.42
EV/EBITDA
28.16
EV/Sales
7.7
The stock's price to earnings (P/E) is 57% more than its 5-year quarterly average of 32.2 and 50% more than its last 4 quarters average of 33.7
TMO's EPS is up by 5% year-on-year
The P/B is 89% above the 5-year quarterly average of 3.3 and 49% above the last 4 quarters average of 4.2
The company's equity rose by 4.6% QoQ and by 4% YoY
The P/S is 82% above the 5-year quarterly average of 3.9 and 48% above the last 4 quarters average of 4.8
Thermo Fisher Scientific's revenue has increased by 6% YoY and by 2.3% from the previous quarter

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital is down by 12% year-on-year and by 8% since the previous quarter
TMO's ROS is down by 9% year-on-year and by 6% since the previous quarter

Dividends

What is TMO's dividend history
DPS
$0.85
Dividend yield
0.18%
Payout ratio
9.1%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 94% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has soared by 101% YoY and by 26% from the previous quarter
The current ratio has surged by 76% year-on-year and by 13% since the previous quarter
The debt is 29% lower than the equity
The debt has increased by 12% YoY and by 7% QoQ
The company's equity rose by 4.6% QoQ and by 4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.